News Sep 20, 2023
Porton Gets Improved in the 2023 S&P Global ESG Score
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
News Sep 13, 2023
Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization and Drug Product Development Services
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
News Aug 29, 2023
Pharma Digital Intelligence Summit will be held on 5th, September, 2023
Join us for a Journey of Innovation at J-STAR Research, Inc.'s Cranbury Open House!
News Aug 09, 2023
J-STAR Research, Inc.'s Cranbury Open House
Join us for a Journey of Innovation at J-STAR Research, Inc.'s Cranbury Open House!
![[Important Notice] Porton Announcement Regarding the Change of Email Domain](/uploads/news/1727576700641997.jpg)
News Jul 28, 2023
[Important Notice] Porton Announcement Regarding the Change of Email Domain
Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe.
News Jun 23, 2023
Porton Pharma Solutions Welcomes Dr. Wenfang Miao as CEO of Porton USA, L.L.C. and J-STAR Research, Inc., Ushering in a New Era of Pharmaceutical Innovation
Join us in welcoming Dr. Wenfang Miao (Renee) as the new CEO of Porton USA, L.L.C. and J-STAR Research, Inc., and Vice-President of Porton Pharma Solutions, LTD. Dr. Miao brings with her more than 25 years of experience in technical, operational, and strategic leadership within the pharmaceutical industry as she will navigate Porton’s overall business strategies, operations, and business development and growth in the United States. We are looking forward to Porton’s stronger foothold in pharmaceutical innovation with her leadership. We are rooting for you, Dr. Miao!
News Jun 23, 2023
Dr. Angelo Maria Manzo of Porton Pharma Solutions Joins BOS Basel 2023, Spearheading Collaborations and Growth Opportunities
Dr. Angelo Maria Manzo, our esteemed Senior Business Development Manager at Porton Pharma Solutions Ltd., joins us at BOS Basel 2023!Angelo’s deep industry knowledge and strategic vision are set to make a remarkable impact as he explores new collaborations, identifies growth opportunities, and expands our network.Drop by Stand 17 to catch up with him during the 2-day event in Basel, Switzerland!
News Jun 23, 2023
Porton Pharma Solutions Welcomes Alexandra Pichard Nielsen, VP of Business Development, at BOS Basel 2023, Driving Innovation and Growth in the Pharmaceutical Industry
We’re honored to have Alexandra Pichard Nielsen, Vice President for Business Development at Porton Pharma Solutions Ltd., join us at BOS Basel 2023!
News Jun 23, 2023
Porton Pharma Solutions Expands Global Reach with New Site in Slovenia and Enhanced Manufacturing Capabilities
Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe.
